Bargal R, Avidan N, Olender T, Ben Asher E, Zeigler M, Raas-Rothschild A, Frumkin A, Ben-Yoseph O, Friedlender Y, Lancet D, Bach G
Department of Human Genetics, Hadassah University Hospital, Jerusalem, Israel.
Hum Mutat. 2001 May;17(5):397-402. doi: 10.1002/humu.1115.
The gene MCOLN1 is mutated in Mucolipidosis type IV (MLIV), a neurodegenerative, recessive, lysosomal storage disorder. The disease is found in relatively high frequency among Ashkenazi Jews due to two founder mutations that comprise 95% of the MLIV alleles in this population [Bargal et al., 2000]. In this report we complete the mutation analysis of Jewish and non-Jewish MLIV patients whose DNA were available to us. Four novel mutations were identified in the MCOLN1 gene of severely affected patients: two missense, T232P and F465L; a nonsense, R322X; and an 11-bp insertion in exon 12. The nonsense mutation (R322X) was identified in two unrelated patients with different haplotypes in the MCOLN1 chromosomal region, indicating a mutation hotspot in this CpG site. An in-frame deletion (F408del) was identified in a patient with unusual mild psychomotor retardation. The frequency of MLIV in the general Jewish Ashkenazi population was estimated in a sample of 2,000 anonymous, unrelated individuals assayed for the two founder mutations. This analysis indicated a heterozygotes frequency of about 1/100. A preferred nucleotide numbering system for MCOLN1 mutations is presented and the issue of a screening program for the detection of high-risk families in the Jewish Ashkenazi population is discussed.
MCOLN1基因在IV型黏脂贮积症(MLIV)中发生突变,MLIV是一种神经退行性隐性溶酶体贮积病。由于两个奠基者突变,该疾病在德系犹太人中出现的频率相对较高,这两个突变占该人群中MLIV等位基因的95%[巴尔加尔等人,2000年]。在本报告中,我们完成了对有DNA可供我们使用的犹太和非犹太MLIV患者的突变分析。在病情严重患者的MCOLN1基因中鉴定出四个新突变:两个错义突变,T232P和F465L;一个无义突变,R322X;以及外显子12中的一个11碱基对插入。在MCOLN1染色体区域具有不同单倍型的两名无关患者中鉴定出无义突变(R322X),表明该CpG位点存在突变热点。在一名有异常轻度精神运动发育迟缓的患者中鉴定出一个框内缺失(F408del)。在一个检测了两个奠基者突变的2000名匿名、无关个体的样本中,估计了德系犹太人群体中MLIV的频率。该分析表明杂合子频率约为1/100。提出了一种用于MCOLN1突变的优选核苷酸编号系统,并讨论了在德系犹太人群体中检测高危家庭的筛查计划问题。